A Review on Diverse Neurological Disorders - Chaurasia, Rameshwar Nath; Ohia, Sunny; Bagchi, Debasis; (ed.) - Prospero Internet Bookshop
Basket (0)
Wishlist (0)
Your personal newsletter
__

A Review on Diverse Neurological Disorders

Pathophysiology, Molecular Mechanisms, and Therapeutics
 
Publisher: Academic Press
Date of Publication:
 
Normal price:
Publisher's listprice:
EUR 220.00
Estimated price in HUF:
93 786 HUF (89 320 HUF + 5% VAT)
Why estimated?
 
Your price:
75 029 (71 456 HUF + 5% VAT )
discount is: 20% (approx 18 757 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
 
Add to basket
  Piece(s)

 
Long description:

A Review of Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics offers an unparalleled compilation of the current understanding of neurodegenerative disorders. This book investigates the origins of mental disorders, encompassing bacterial and fungal invasions, viral assaults, and genetic predispositions, providing readers with a thorough grasp of the neurological landscape. Each chapter dissects the intricacies of these incapacitating conditions, ranging from the pathogenesis of central nervous system tuberculosis to the involvement of endocannabinoids in rabies infection. Topics such as neuroinflammation, axonal pathology, and the intricate relationship between diet, gut microbiomes, and cognitive decline are also explored. This book conducts an extensive examination of neurodegeneration, incorporating discussions on the role of probiotics and natural bioactive compounds in preventing ailments such as Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). With meticulous analyses of vitamins, micronutrients, antioxidants, and nutraceuticals, this work offers a roadmap for promoting neuroprotection. A Review of Diverse Neurological Disorders serves as a resource that not only reviews the current understanding but also lays the groundwork for future treatments and innovations.




  • Epidemiology of neurological disorders and pathogenesis.
  • Explores neuroinflammation, ligand-receptors binding, and neurodegeneration.
  • Discusses aging and associated disorders in the onset of neurological disorders.
  • Neuropharmacology and the protective role of bioactive compounds in neuroprotection.
Table of Contents:
  1. Epidemiology and risk factors of mental disorders
  2. Bacterial meningitis and neurological disorder
  3. An overview on Helminthic brain infections in humans
  4. Helminthic infections of the central nervous system
  5. Pathogenesis and overview of central nervous system tuberculosis
  6. Tuberculosis of central nervous system
  7. An overview on tetanus, diphtheria, and diverse bacterial infections of the CNS
  8. Tetanus, diphtheria and other bacterial infections of central nervous system
  9. Pathogenesis and treatment of syphilis
  10. Fungal infection of central nervous system
  11. An overview on the fungal infections of the nervous system
  12. Acute viral encephalitis, meningitis, and cerebral malaria
  13. Neurological complications of COVID-19 infections
  14. Genetic addiction risk analysis for “Preaddiction Severity Index” (PAI): A neurobiological behavioral octupus
  15. Addressing the role of endocannabinoid system in rabies infection and its potential for modulation
  16. Pathogenesis and Treatment of Rabies
  17. An overview of pathophysiology and therapeutic approaches of Alzheimer’s disease and Parkinson’s disease
  18. Ataxia and motor neuron diseases
  19. Multiple system atrophy
  20. Progressive supranuclear palsy
  21. Epilepsy and Neurodegeneration
  22. HIV/AIDS Neurological Disorders
  23. Neurodegeneration and Motor Deficits
  24. Neurodegeneration in autoimmune central nervous system infection
  25. Inflammation and neurodegeneration in multiple sclerosis
  26. Autophagy and mitophagy in amyotrophic lateral sclerosis
  27. Excitation-inhibition balance in diseases of the brain: Role of NMDA and GABA receptors
  28. Nutraceuticals for the prevention of stroke and cerebrovascular injury: An overview
  29. HIV infection, type 1 interferons, and immune competence: Correlating brain immunity to neurodegeneration
  30. Neuroinflammation: Role of adhesion molecules and signaling networks in neurovascular systems
  31. Influence of Axonal Pathology in Traumatic Brain Injury
  32. Axonal Pathology in Traumatic Brain Injury: An Overview
  33. Ocular neurodegenerative disorders
  34. Stress-associated neurodegenerative disorders: A mechanistic exploration
  35. Diverse stress and neurodegeneration: An overview
  36. Neurodegenerative diseases and circadian rhythm dysfunction: A bidirectional nexus
  37. Advancing age, nutraceuticals, and neuroprotection
  38. Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults
  39. CNS drugs: Classification, characterization, and binding properties towards biomacromolecules
  40. The role of gut microbiome in insomnia
  41. Novel therapeutics for diverse neurological disorders
  42. Elucidating the potential of natural bioactive compounds in neuroprotection
  43. Vitamins, micronutrients, antioxidants, and nutraceuticals in neuroprotection: An overview
  44. Olive oil and mediterranean diet: The importance of olive oil constituents, and mainly of its polyphenols, in human health - The redox system - Xenohormesis hypothesis
  45. Probiotics protect against progressive deterioration of motor functions and Parkinson’s disease
  46. Neuroprotective abilities of vitamins, micronutrients, antioxidants, and nutraceuticals
  47. Nutraceuticals and Natural Products in the treatment of neurological disorders
  48. Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders
  49. The Threats and Therapeutics of Neurodegenerative Disorders: A Commentary